Enjoy complimentary customisation on priority with our Enterprise License!
The blood pressure (BP) transducers market size is estimated to grow by USD 128.65 million at a CAGR of 5.32% between 2022 and 2027. There is an increasing focus on preventive healthcare due to the growing awareness about healthcare imparted by healthcare professionals. Several healthcare reforms regarding preventive care have significantly minimized healthcare expenditure without compromising on the quality of treatments. Additionally, there is an increasing focus on early diagnosis among several healthcare organizations in order to reduce the burden on curative treatments, which are very expensive and can significantly impact healthcare organizations. The main purpose of blood pressure transducers is to prevent severe events in critically ill patients, which are caused by sudden increases in blood pressure through early diagnosis. The main advantage of preventive healthcare is that it can significantly reduce the expense of healthcare and hospitalizations. By utilizing these, individuals can regularly monitor their blood pressure, and diseases can be prevented. Hence, such factors are positively impacting the market. This market research and growth report also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021 besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
Technavio has segmented the market into Product, End-user, and Geography. The market encompasses pulse monitoring equipment designed for measuring and recording arterial, venous, intracranial, and intra-abdominal pressures. These transducers convert mechanical changes in BP into electrical analogue signals for monitoring in hospitals, clinics, ambulatory surgical centers, and diagnostic laboratories. The geriatric population and those with an inactive lifestyle or hypertension significantly benefit from these devices. Sensors integrated into these transducers capture biological signals, including arterial and central venous pressures, and convert them into electrical signals. The one-time use feature of disposable blood pressure transducers reduces the risk of hospital-acquired infections and lowers costs compared to reusable transducers. Applications include animals, chest-monitoring devices, and human vitals monitoring in adults. Launches of new products, such as Biobeat, Valencell, and various wearables, like smartwatches, fitness bands, patches, and hearable devices, expand the taxonomy of this market.
The disposable blood pressure transducers segment is estimated to witness significant growth during the forecast period. Disposable blood pressure transducers can be referred to as invasive hemodynamic systems that change as per the mechanical changes in BP into electrical current, which is recorded by a pressure monitoring system. The main purpose of the disposable segment is the direct measurement and monitoring of BP, but they are only intended for one-time use.
Get a glance at the market contribution of various segments View a PDF Sample
The disposable blood pressure transducers segment was the largest segment and was valued at USD 253.26 million in 2017. There is an increasing adoption of disposable blood transducers as they are safe and effective. This segment directly estimates BP from a suitable artery. The measurement by this segment is accurate, and the single-use feature significantly helps to minimize the risk of hospital-acquired infections.
Additionally, the cost of disposable ones is significantly less than the cost of reusable blood pressure transducers, which makes it affordable for most of the population. There is an increasing focus by several market players in the global market for manufacturing disposable oness. For example, Deltran, developed by a prominent market player, Utah Medical Products, is a disposable blood pressure transducer that includes features such as the ability to provide consistent and accurate readings during blood pressure monitoring. Hence, such factors are expected to fuel the growth of this segment, which in turn will drive the market growth during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The market encompasses various types of tools for measuring BP, including reusable Aneroid and digital devices. Technology advances have led to the development of wearable, non-invasive transducers that provide real-time electrical digital signals. These tools are essential for detecting high BP, a condition affecting numerous organs, including the heart, blood vessels, and arteries. Invasive procedures involve the use of catheters to directly measure pressure within the arteries. Non-invasive methods, on the other hand, use external sensors. Both methods offer precision and are crucial in managing cardiovascular diseases, particularly in geriatric populations and those with pre-hypertension, diabetes, obesity, sedentary behavior, alcohol consumption, tobacco consumption, cholesterol, and other risk factors. Government efforts to improve healthcare systems and reduce the global mortality rate from conditions like stroke, heart disease, and kidney failure have fueled the demand for accurate and portable BP transducers. Smoking and other lifestyle factors contribute significantly to high BP, making the portability and ease of use of these devices essential.
Buy Now Full Report and Discover More
The market encompasses pulse monitoring equipment essential for the geriatric population and those with an inactive lifestyle, particularly those suffering from hypertension. Hospitals, clinics, ambulatory surgical centers, and diagnostic laboratories utilize these transducers to measure various pressures, including arterial, venous, intracranial, intra-abdominal, and central venous pressures. Sensors convert biological signals into electrical analogue signals, which pressure transducers then measure and convert into pressure readings. Animals also benefit from these devices in veterinary applications. The increasing number of deaths due to cardiovascular diseases among adults necessitates the use of chest-monitoring devices and human vitals measurement equipment, further fueling market growth. Medication administration and continuous monitoring are crucial aspects of patient care, making these an indispensable component in healthcare settings. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
One of the key factors driving the global blood market growth is the increasing incidence of hypertension. Circulatory strain is a critical health concern, with hypertension being a significant risk factor leading to various health complications. Hypertension, characterized by BP above 130/80 mmHg, affects adults and geriatric populations, often resulting from an inactive lifestyle. This condition increases the risk of diseases such as stroke, heart disease, kidney failure, and cognitive impairment. To monitor and manage BP, various pulse monitoring equipment, including circulatory strain transducers, are utilized in hospitals, clinics, ambulatory surgical centers, and diagnostic laboratories.
These devices convert biological signals into electrical analogue signals, enabling accurate measurement of arterial, venous, intracranial, and intra-abdominal pressures. Sensors and pressure transducers play a crucial role in this process, with applications extending to animals and central venous pressure monitoring. The healthcare continuum benefits from continuous monitoring, reducing deaths and improving patient care. Launches of innovative products like Biobeat's chest-monitoring device, Valencell's wearables, and various hearable, ear-based devices, smartwatches, fitness bands, and patches contribute to the taxonomy of this market. Disposable sensors and patches offer convenience and affordability, making them increasingly popular.
A key factor shaping the global market growth is the growing adoption of product bundling strategy by vendors. Circulatory strain transducer, also known as blood pressure transducer, have gained popularity over traditional reusable models due to the risk of healthcare-associated infections. The Centers for Disease Control and Prevention (CDC) reports that approximately 1% of patients in the US experience a healthcare-associated infection daily. To mitigate this concern, various healthcare facilities, including hospitals, clinics, ambulatory surgical centers, and diagnostic laboratories, opt for disposable transducers. These transducers ensure basic hygiene and sanitation, thereby reducing infection rates.
Sensors in pulse monitoring equipment convert biological signals into electrical analogue signals, which these measure as arterial, venous, intracranial, intra-abdominal, or central venous pressures. Disposable transducers are also used in animals and human vitals monitoring in various settings, from physical examinations to wearables such as smartwatches, fitness bands, patches, hearables, and hearing aids. The taxonomy of blood pressure transducers includes disposable options catering to the needs of diverse populations, including geriatric individuals and those with inactive lifestyles, and those dealing with hypertension. Launches of innovative products like Biobeat's chest-monitoring device and Valencell's wearables continue to expand the healthcare continuum.
Product recalls and stringent regulations are one of the key challenges hindering the market growth. Blood pressure transducers, also known as circulatory strain transducer, are medical devices used to measure arterial, venous, intracranial, and intra-abdominal pressures by inserting a cannula needle into a patient's artery. This invasive method is commonly used in hospitals, clinics, ambulatory surgical centers, and diagnostic laboratories for intensive care and surgical procedures. However, due to the risks of infection and trauma, non-invasive methods such as pulse monitoring equipment using sensors to detect biological signals and convert them into electrical analogue signals have gained popularity. These non-invasive methods are preferred in the geriatric population and those with an inactive lifestyle or hypertension.
Wearable devices like chest-monitoring devices, smartwatches, fitness bands, patches, hearables, and ear-based devices are increasingly being used to monitor human vitals continuously. The taxonomy of this market includes disposable and reusable pressure transducers used for measuring arterial, venous, central venous, and other pressures in adults and animals. Despite the availability of non-invasive methods, invasive blood pressure monitoring continues to be essential in certain medical situations. Recent launches in this field include Biobeat's non-invasive blood pressure monitoring system and Valencell's wearable sensor technology. The healthcare continuum benefits from the advancements in this field, reducing the number of deaths caused by undetected pressure imbalances.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
ADInstruments Pty Ltd: The company offers disposable blood-pressure transducers MLT0670 and MLT0699.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is a significant segment in the healthcare industry, driven by the increasing prevalence of cardiovascular diseases and hypertension. These transducers convert the mechanical pressure into an electrical signal, enabling accurate blood pressure measurement. The market is witnessing growth due to the rising demand for non-invasive blood pressure monitoring devices and the development of advanced technologies such as wireless and smart transducers. Key players in the market include Chestnut Medical Technologies, Deltex Medical, Edwards Lifesciences, and Spacelabs Healthcare. They focus on product innovation and expansion of their product portfolios to cater to the evolving market needs.
The market is also influenced by factors such as government initiatives to promote preventive healthcare and the growing geriatric population. They are used in various applications, including clinical settings, home healthcare, and ambulatory monitoring. The market is expected to grow at a steady pace due to the increasing adoption of advanced technologies and the rising demand for portable and wireless devices. The market is segmented based on product type, application, and end-user. The market for wireless and smart transducers is expected to grow at a significant rate due to their convenience and ease of use. The market introduces innovative solutions like the circulatory strain transducer and fibre optic blood transducers for precise monitoring of arterial pressures and intracranial pressures, complemented by remote patient monitoring solutions and cuff-less blood pressure technology.
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Market Scope |
|
Report Coverage |
Details |
Page number |
160 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.32% |
Market growth 2023-2027 |
USD 128.65 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
4.99 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 36% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
ADInstruments Pty Ltd., B L Lifesciences Pvt Ltd., B.Braun SE, BIOPAC Systems Inc., CODAN Medizinische Gerate GmbH and Co KG, Edwards Lifesciences Corp., Elcam Medical Group, Harvard Bioscience Inc., ICU Medical Inc., iWorx Systems Inc., Koninklijke Philips N.V., Masimo Corp., MEMSCAP SA, Merit Medical Systems Inc., SCW Medicath Ltd., Smiths Group Plc, UGO BASILE S.R.L., Utah Medical Products Inc., World Precision Instruments, and Biosensors International Group Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.